WX (Wuxi Pharmatech) is a competitor and just went public in US with a big market cap, backed by Fidelity and a few other US-known VCs. They have all big pharma as clients, and VRTX is the biggest client with Hep C the target. It is based in Shanghai, and is up 50% from IPO.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.